Therapeutic potential of hepcidin − the master regulator of iron metabolism
- 1 January 2017
- journal article
- review article
- Published by Elsevier in Pharmacological Research
- Vol. 115, 242-254
Abstract
No abstract availableKeywords
Funding Information
- European Regional Development Fund (CZ.1.05/1.1.00/02.0109)
- Ministerstvo Školství, Mládeže a Tělovýchovy (PRVOUK P24/LF1/3, SVV 260 265/2016)
- Grantová Agentura České Republiky (15-14200S)
- Ministerstvo Zdravotnictví Ceské Republiky (00023736, 15-32961A, ERDF OPPK CZ.2.16/3.1.00/24001, ERDF OPPK CZ.2.16/3.1.00/28007)
This publication has 132 references indexed in Scilit:
- The long history of iron in the Universe and in health and diseaseBiochimica et Biophysica Acta (BBA) - General Subjects, 2012
- Pharmacological Suppression of Hepcidin Increases Macrophage Cholesterol Efflux and Reduces Foam Cell Formation and AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- Targeting the hepcidin–ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammationAmerican Journal of Hematology, 2011
- BMP6 Treatment Compensates for the Molecular Defect and Ameliorates Hemochromatosis in Hfe Knockout MiceGastroenterology, 2010
- BMP6 is a key endogenous regulator of hepcidin expression and iron metabolismNature Genetics, 2009
- The Serine Protease TMPRSS6 Is Required to Sense Iron DeficiencyScience, 2008
- Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)Nature Genetics, 2008
- Posttranslational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furinBlood Cells, Molecules, and Diseases, 2008
- Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolismNature Chemical Biology, 2007
- Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balanceJournal of Clinical Investigation, 2007